Last Updated: August 8, 2026

Drug Price Trends for ONEXTON GEL PUMP


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ONEXTON GEL PUMP

Market Analysis and Price Projections for ONEXTON GEL PUMP

Last updated: March 8, 2026

What is ONEXTON GEL PUMP?

ONEXTON Gel Pump is a topical treatment containing clindamycin phosphate and benzoyl peroxide, indicated for acne vulgaris. It combines antimicrobial and keratolytic effects targeting inflammatory and non-inflammatory acne lesions.

Market Overview

Incidence and Prevalence

  • Acne vulgaris affects approximately 85% of adolescents and young adults aged 12-24 in the U.S. (American Academy of Dermatology Association, 2022).
  • The global acne treatment market size was valued at USD 4.6 billion in 2021 and is projected to grow at a CAGR of 4.2% through 2030 (Grand View Research, 2022).

Competitive Landscape

Key competitors include:

  • Differin (adapalene)
  • Epiduo (adapalene and benzoyl peroxide)
  • Cleocin T (clindamycin topical)
  • Benzaclin (benzoyl peroxide and clindamycin)

Despite competitive pressure, ONEXTON's unique formulation and pump delivery system can provide differentiating advantages in convenience and dosing accuracy.

Distribution Channels

  • Dermatology clinics
  • Pharmacies (retail and specialty)
  • Direct-to-consumer via online platforms

Regulatory Status

  • Approved by FDA in 2014 for topical treatment of acne vulgaris.
  • No new formulations or delivery systems approved since initial launch.

Pricing Analysis

Current Market Prices

Product Typical Price Range (USD) Formulation Details Pricing Notes
ONEXTON Gel Pump USD 340 - 400 per 60 g Pump delivery, 1% clindamycin phosphate, 5% benzoyl peroxide Premium price; convenience and pump delivery considered value-add
Epiduo Gel USD 290 - 330 per 45 g 0.1% adapalene + 2.5% benzoyl peroxide Slightly lower price, no pump system
Cleocin T Solution USD 200 - 220 per 15 g Clindamycin 1% topical solution Lower price, different formulation

Pricing Drivers

  • Patent status: ONEXTON's patent protection lasts until 2030, supporting premium pricing.
  • Delivery system: Pump formulation improves user dosing accuracy, justifying higher price.
  • Market segmentation: Targeting dermatology practices enables premium pricing strategies.
  • Competitive pressures: Prices tend to remain stable unless new entrants or formulations disrupt the market.

Price Projections

Short-term (Next 1-2 Years)

  • Expect stabilization at current levels, USD 340-400 per 60 g, supported by patent protections.
  • Minor discounts possible as part of clinical trial or formularies negotiations.

Medium-term (3-5 Years)

  • Potential increment due to inflation and increased demand for targeted acne treatments.
  • Projected price increase of 2-4% annually, reaching USD 370-440 per 60 g by 2027.

Long-term (Beyond 5 Years)

  • Patent expiry coverage until 2030 may see price compression post-patent due to generics.
  • After patent expiry, price likely drops by 40-60%, aligning with generic formulations (USD 180-250 per 60 g).

Impact of Potential Market Dynamics

  • Generic competition post-2030 could force downward price adjustments.
  • Market entry of biosimilars or alternative delivery systems may influence pricing strategies.
  • Regulatory changes and new formulations could shift demand and value perceptions.

Market Penetration Strategy

  • Focus on dermatology specialists with premium pricing considering convenience.
  • Develop patient education programs highlighting the benefits of pump delivery to justify higher prices.
  • Engage in formulary negotiations to balance volume and revenue.

Key Takeaways

  • On the market since 2014, ONEXTON Gel Pump is positioned as a premium topical acne treatment due to its delivery system and formulation.
  • Short-term price stability is expected, with prices around USD 340-400 per 60 g.
  • Post-2030, price drops are projected as generics enter the market.
  • Growing demand in global markets supports moderate price increases before patent expiration.
  • Competitive positioning relies on differentiation via packaging, convenience, and formulary access.

FAQs

1. How does ONEXTON Gel Pump compare to other acne treatments in terms of price?
It commands a higher price, approximately USD 340-400 per 60 g, due to its pump delivery system and formulation. Competitors like Epiduo are priced lower at USD 290-330 per 45 g.

2. What factors could influence ONEXTON's pricing strategy in the future?
Patent expiration, competitive entries, regulatory changes, and market demand fluctuations are primary factors affecting future pricing.

3. Will the pump delivery system justify a higher price over traditional gels?
Yes, offering dosing accuracy and convenience, which can be valued by dermatologists and patients. It supports premium pricing especially in dermatology practice settings.

4. When are generics expected to affect ONEXTON's price?
Post-2030, once patent exclusivity ends, generics could reduce prices by 40-60%.

5. How does regional variation impact pricing?
Prices tend to be higher in North America and Europe; emerging markets may see lower prices due to market competition and purchasing power differences.


Sources:
[1] American Academy of Dermatology Association. (2022). Acne statistics.
[2] Grand View Research. (2022). Acne Treatment Market Size & Trends.
[3] U.S. Food and Drug Administration. (2014). ONEXTON label approval.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.